Contact
searchSearch
HMP Global

Skin Cancer Videos

nahid vidal
Videos
Mohs Surgery for Anogenital and Perineal Tumors: Expert Insights
07/08/2025
Nahid Y. Vidal, MD, FAAD
In this video, Dr Nahid Vidal delves into the complexities of managing anogenital tumors with Mohs surgery.
In this video, Dr Nahid Vidal delves into the complexities of managing anogenital tumors with Mohs surgery.
In this video, Dr Nahid Vidal...
07/08/2025
The Dermatologist
Ramone F. Williams, MD, MPhil
Videos
Mohs Surgeons Leading the Future: Advancing Careers and Care
06/14/2024
Ramone F. Williams, MD
In this interview, Dr Ramone F. Williams discusses the Mohs Surgeons Leading the Future program and highlights the program's objectives, the specific projects undertaken, and the valuable lessons learned by participants in enhancing their...
In this interview, Dr Ramone F. Williams discusses the Mohs Surgeons Leading the Future program and highlights the program's objectives, the specific projects undertaken, and the valuable lessons learned by participants in enhancing their...
In this interview, Dr Ramone F....
06/14/2024
The Dermatologist
Dr Patel
Videos
Advances in High-Risk Cutaneous Squamous Cell Carcinoma
05/07/2024
Vishal K. Patel, MD
In this interview, Dr Vishal Patel discusses recent advances in high-risk cutaneous squamous cell carcinoma, focusing on gene expression profiling and promising treatment approaches.
In this interview, Dr Vishal Patel discusses recent advances in high-risk cutaneous squamous cell carcinoma, focusing on gene expression profiling and promising treatment approaches.
In this interview, Dr Vishal...
05/07/2024
The Dermatologist
Dr David Carr
Videos
Advancing a Mohs Surgery Leadership Program
04/03/2024
David R. Carr, MD, MPH, FACMS
In this interview, Dr Carr delves into the Mohs Surgeons Leading the Future project, discussing its objectives, specific projects, selection criteria, and outcomes. Discover how these initiatives contribute to the advancement of Mohs surgery...
In this interview, Dr Carr delves into the Mohs Surgeons Leading the Future project, discussing its objectives, specific projects, selection criteria, and outcomes. Discover how these initiatives contribute to the advancement of Mohs surgery...
In this interview, Dr Carr...
04/03/2024
The Dermatologist
Travis Blalock
Videos
Enhancing Dermatologic Surgery Skills: Insights and Strategies
04/01/2024
Travis W. Blalock, MD
In this interview, Dr Travis Blalock shares valuable insights on dermatologic surgery for non-Mohs surgeons. From identifying key surgical pearls to managing challenges like bleeding and tension, Blalock shares invaluable strategies and...
In this interview, Dr Travis Blalock shares valuable insights on dermatologic surgery for non-Mohs surgeons. From identifying key surgical pearls to managing challenges like bleeding and tension, Blalock shares invaluable strategies and...
In this interview, Dr Travis...
04/01/2024
The Dermatologist
Elliott Campbell
Videos
Cutaneous Melanoma Trends in Middle-Aged Adults: Rising Incidence and Shifting Mortality
12/01/2023
Elliott Campbell, MD, FAAD
In this interview, Dr Elliott Campbell discussed the rise in melanoma among middle-aged women, attributing it to factors like sun exposure and past tanning bed use.
In this interview, Dr Elliott Campbell discussed the rise in melanoma among middle-aged women, attributing it to factors like sun exposure and past tanning bed use.
In this interview, Dr Elliott...
12/01/2023
The Dermatologist
Emily Ruiz
Videos
Advancements in Non-Surgical Skin Cancer Treatments
10/06/2023
Emily Ruiz, MD, MPH
In this exclusive interview, Dr Emily Ruiz explores innovative non-surgical treatments for skin cancers, from injectables to topical therapies and systemic agents.
In this exclusive interview, Dr Emily Ruiz explores innovative non-surgical treatments for skin cancers, from injectables to topical therapies and systemic agents.
In this exclusive interview, Dr...
10/06/2023
The Dermatologist
Dr Soon
Videos
Mohs Surgery for Keratinocyte Carcinoma
07/01/2023
Seaver L. Soon, MD
In this interview, Dr Seaver Soon discussed his session, “Pro and Con: Contentious Concepts,” at the 2023 ACMS Annual Meeting. He covered the topic, “Superficial Radiation vs Mohs for Keratinocyte Carcinoma: Pro Mohs.”
In this interview, Dr Seaver Soon discussed his session, “Pro and Con: Contentious Concepts,” at the 2023 ACMS Annual Meeting. He covered the topic, “Superficial Radiation vs Mohs for Keratinocyte Carcinoma: Pro Mohs.”
In this interview, Dr Seaver...
07/01/2023
The Dermatologist
Dr Walayat Hussain
Videos
Key Insights: International Perspectives on Mohs
06/30/2023
Walayat Hussain, BSc, MBChB, MRCP, FRACP, FACMS
In this exclusive interview with The Dermatologist, Dr Walayat Hussain shared insights into his session, “International Perspectives on Mohs & Facial Reconstruction,” presented at the American College of Mohs Surgery Annual Meeting.
In this exclusive interview with The Dermatologist, Dr Walayat Hussain shared insights into his session, “International Perspectives on Mohs & Facial Reconstruction,” presented at the American College of Mohs Surgery Annual Meeting.
In this exclusive interview with...
06/30/2023
The Dermatologist
Dr Julia Siegel
Videos
The Medical Necessity of Sunscreen Access
10/21/2021
Julia A. Siegel, MD
Dr Julia Siegel discusses the medical necessity of sunscreen and how she's working to help make it easier for people to access while traveling.
Dr Julia Siegel discusses the medical necessity of sunscreen and how she's working to help make it easier for people to access while traveling.
Dr Julia Siegel discusses the...
10/21/2021
The Dermatologist

Popular Articles

Derm Dx
What Is the Cause of These Waxy, Dermal Papules?
10/20/2023
Raza Khan, BS; Pamela Allen, MD
A 45-year-old woman with Fitzpatrick II skin phototype presented with a 7-month history of a widespread, pruritic rash unchanged by levocetirizine 5 mg twice daily and hydroxyzine 25 mg every night at bedtime.
A 45-year-old woman with Fitzpatrick II skin phototype presented with a 7-month history of a widespread, pruritic rash unchanged by levocetirizine 5 mg twice daily and hydroxyzine 25 mg every night at bedtime.
A 45-year-old woman with...
10/20/2023
The Dermatologist
Emma Guttman
Conference Coverage
AA Pathophysiology: Immune Pathway Insights
12/02/2023
Riya Gandhi, MA
During her session, Emma Guttman-Yassky, MD, PhD, discussed how alopecia areata is more complicated than previously thought, and how there are multiple clinical phenotypes with immune abnormalities.
During her session, Emma Guttman-Yassky, MD, PhD, discussed how alopecia areata is more complicated than previously thought, and how there are multiple clinical phenotypes with immune abnormalities.
During her session, Emma...
12/02/2023
The Dermatologist
psoriatic arthritis
News
Sex-Related Differences in Psoriatic Arthritis Randomized Clinical Trials
01/24/2024
Jessica Garlewicz
Researchers aimed to investigate sex-related differences in patient characteristics, efficacy, and safety outcomes of advanced therapies in psoriatic arthritis.
Researchers aimed to investigate sex-related differences in patient characteristics, efficacy, and safety outcomes of advanced therapies in psoriatic arthritis.
Researchers aimed to investigate...
01/24/2024
The Dermatologist
NAAF-Reviewed Content
Alopecia Areata and its Connections With Atopic Dermatitis
03/05/2024
Riya Gandhi, MA
This interview provides valuable insights for dermatologists navigating the complexities of alopecia areata and its relationships with atopic dermatitis.
This interview provides valuable insights for dermatologists navigating the complexities of alopecia areata and its relationships with atopic dermatitis.
This interview provides valuable...
03/05/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Riya Gandhi, MA
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist

Subscribe

The Dermatologist Newsletter
New Issue - September 2025

Current Issue

September 2025
Volume 33
Issue 6
Current Issue
Issue Archive

Latest Quizzes and Trivia

acne
Quiz
Quiz: Pathophysiologic Pillars of Acne
09/25/2025
Jessica Garlewicz
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1...
09/25/2025
The Dermatologist
psoriasis
Quiz
Quiz: Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
09/25/2025
Jessica Garlewicz
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical...
09/25/2025
The Dermatologist
Quiz
When Should You Start a JAK Inhibitor for AA?
09/22/2025
Riya Gandhi, MA
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they...
09/22/2025
The Dermatologist
Quiz
Which Systemic Therapy Raises Red Flags in Older Adults?
09/18/2025
Riya Gandhi, MA
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special...
09/18/2025
The Dermatologist
Quiz
How Long Before You Call a JAK Inhibitor Non-Responsive?
09/15/2025
Riya Gandhi, MA
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial...
09/15/2025
The Dermatologist
Quiz
What’s the Go-To Adjunct With JAKs in AA Regrowth?
09/08/2025
Riya Gandhi, MA
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but...
09/08/2025
The Dermatologist
psoriasis
Quiz
NPF Quiz: The Primary Goal of the S.T.R.A.N.D. Network
09/04/2025
Jessica Garlewicz
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals...
09/04/2025
The Dermatologist
Quiz
Ethical Arguments in AA: Cosmetic vs. Medical
08/21/2025
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in...
08/21/2025
The Dermatologist
psoriasis
Quiz
True or False: TYK2 Inhibition
08/14/2025
Jessica Garlewicz
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition...
08/14/2025
The Dermatologist
alopecia areata
Quiz
Alopecia Areata—JAK Inhibitor Indications
08/14/2025
Jessica Garlewicz
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients...
08/14/2025
The Dermatologist

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use